Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial
(1) Background: Mitomycin C (MMC) is commonly used during trabeculectomy. However, there is no consensus on which concentration should be used. We aimed to compare the efficacy and safety of 0.2 mg/mL and 0.4 mg/mL of MMC in eyes undergoing trabeculectomy. (2) Methods: Thirty-six eyes (36 glaucoma p...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-12-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/1/59 |
| _version_ | 1797543468239683584 |
|---|---|
| author | Bo Ram Seol Sang Yoon Lee Yu Jeong Kim Young Kook Kim Jin Wook Jeoung Ki Ho Park |
| author_facet | Bo Ram Seol Sang Yoon Lee Yu Jeong Kim Young Kook Kim Jin Wook Jeoung Ki Ho Park |
| author_sort | Bo Ram Seol |
| collection | DOAJ |
| description | (1) Background: Mitomycin C (MMC) is commonly used during trabeculectomy. However, there is no consensus on which concentration should be used. We aimed to compare the efficacy and safety of 0.2 mg/mL and 0.4 mg/mL of MMC in eyes undergoing trabeculectomy. (2) Methods: Thirty-six eyes (36 glaucoma patients) were randomized to undergo a trabeculectomy with 0.2 mg/mL or 0.4 mg/mL of MMC. The success rate was evaluated according to three criteria: (A) intraocular pressure (IOP) ≤ 18 mmHg and IOP reduction ≥ 20%; (B) IOP ≤ 15 mmHg and IOP reduction ≥ 25%; (C) IOP ≤ 12 mmHg and IOP reduction ≥ 30%. Cox’s proportional hazard model was used to identify the predictive factors for failure. Immunohistochemical procedures for matrix metalloproteinase (MMP) were performed on Tenon’s tissue. Bleb morphology was evaluated. Safety was assessed based on the incidence of complications. (3) Results: Of the 36 eyes, 19 underwent trabeculectomy with 0.2 mg/mL of MMC and 17 with 0.4 mg/mL. The success rates were 75%, 67%, and 47% at 6 months for criteria A, B, and C, respectively. There were no significant differences between the two groups. High MMP-9 staining and low preoperative IOP were associated with failure (hazard ratio (HR), 5.556; <i>p</i> = 0.033, and HR, 0.936; <i>p</i> = 0.033). Complications included hypotony in two eyes (6%), hyphema in one eye (3%), and choroidal detachment in one eye (3%). (4) Conclusions: Trabeculectomy with 0.2 mg/mL and 0.4 mg/mL of MMC showed similar IOP-control effects to those recorded in previous studies, along with a low rate of complications. There was no significant difference in efficacy or safety between the 0.2 mg/mL and 0.4 mg/mL MMC groups. |
| first_indexed | 2024-03-10T13:45:59Z |
| format | Article |
| id | doaj.art-e7caeb75466d4e39b3e468f12bff8f18 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T13:45:59Z |
| publishDate | 2020-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-e7caeb75466d4e39b3e468f12bff8f182023-11-21T02:40:01ZengMDPI AGJournal of Clinical Medicine2077-03832020-12-011015910.3390/jcm10010059Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical TrialBo Ram Seol0Sang Yoon Lee1Yu Jeong Kim2Young Kook Kim3Jin Wook Jeoung4Ki Ho Park5Department of Ophthalmology, Seoul National University College of Medicine, Seoul 08826, KoreaDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul 08826, KoreaDepartment of Ophthalmology, Seoul National University Hospital, Seoul 03080, KoreaDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul 08826, KoreaDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul 08826, KoreaDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul 08826, Korea(1) Background: Mitomycin C (MMC) is commonly used during trabeculectomy. However, there is no consensus on which concentration should be used. We aimed to compare the efficacy and safety of 0.2 mg/mL and 0.4 mg/mL of MMC in eyes undergoing trabeculectomy. (2) Methods: Thirty-six eyes (36 glaucoma patients) were randomized to undergo a trabeculectomy with 0.2 mg/mL or 0.4 mg/mL of MMC. The success rate was evaluated according to three criteria: (A) intraocular pressure (IOP) ≤ 18 mmHg and IOP reduction ≥ 20%; (B) IOP ≤ 15 mmHg and IOP reduction ≥ 25%; (C) IOP ≤ 12 mmHg and IOP reduction ≥ 30%. Cox’s proportional hazard model was used to identify the predictive factors for failure. Immunohistochemical procedures for matrix metalloproteinase (MMP) were performed on Tenon’s tissue. Bleb morphology was evaluated. Safety was assessed based on the incidence of complications. (3) Results: Of the 36 eyes, 19 underwent trabeculectomy with 0.2 mg/mL of MMC and 17 with 0.4 mg/mL. The success rates were 75%, 67%, and 47% at 6 months for criteria A, B, and C, respectively. There were no significant differences between the two groups. High MMP-9 staining and low preoperative IOP were associated with failure (hazard ratio (HR), 5.556; <i>p</i> = 0.033, and HR, 0.936; <i>p</i> = 0.033). Complications included hypotony in two eyes (6%), hyphema in one eye (3%), and choroidal detachment in one eye (3%). (4) Conclusions: Trabeculectomy with 0.2 mg/mL and 0.4 mg/mL of MMC showed similar IOP-control effects to those recorded in previous studies, along with a low rate of complications. There was no significant difference in efficacy or safety between the 0.2 mg/mL and 0.4 mg/mL MMC groups.https://www.mdpi.com/2077-0383/10/1/59efficacymitomycin Ctrabeculectomysafety |
| spellingShingle | Bo Ram Seol Sang Yoon Lee Yu Jeong Kim Young Kook Kim Jin Wook Jeoung Ki Ho Park Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial Journal of Clinical Medicine efficacy mitomycin C trabeculectomy safety |
| title | Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial |
| title_full | Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial |
| title_fullStr | Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial |
| title_full_unstemmed | Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial |
| title_short | Comparison of the Efficacy and Safety of Trabeculectomy with Mitomycin C According to Concentration: A Prospective Randomized Clinical Trial |
| title_sort | comparison of the efficacy and safety of trabeculectomy with mitomycin c according to concentration a prospective randomized clinical trial |
| topic | efficacy mitomycin C trabeculectomy safety |
| url | https://www.mdpi.com/2077-0383/10/1/59 |
| work_keys_str_mv | AT boramseol comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial AT sangyoonlee comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial AT yujeongkim comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial AT youngkookkim comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial AT jinwookjeoung comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial AT kihopark comparisonoftheefficacyandsafetyoftrabeculectomywithmitomycincaccordingtoconcentrationaprospectiverandomizedclinicaltrial |